uniQure N.V. (NASDAQ: QURE)
$15.9000
-0.0200 ( -1.06% ) 0.1K
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
Market Data
Open
$15.9000
Previous close
$15.9200
Volume
0.1K
Market cap
$780.49M
Day range
$15.6200 - $16.4490
52 week range
$3.7300 - $19.1800
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Aug 01, 2024 |
10-q | Quarterly Reports | 72 | Aug 01, 2024 |
8-k | 8K-related | 15 | Jul 23, 2024 |
8-k | 8K-related | 15 | Jul 09, 2024 |
8-k | 8K-related | 15 | Jul 01, 2024 |
4 | Insider transactions | 1 | Jun 28, 2024 |
4 | Insider transactions | 1 | Jun 21, 2024 |
4 | Insider transactions | 1 | Jun 21, 2024 |
4 | Insider transactions | 1 | Jun 21, 2024 |
4 | Insider transactions | 1 | Jun 21, 2024 |